Has Brian Eisner, MD received payments from drug or device companies?

Yes. Drug and device makers reported $424,449 in general payments to Brian Eisner, MD across 200 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Brian Eisner, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Brian Eisner, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Brian Eisner, MD

Urology · Boston, MANPI 1013043488

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (46.8%), speaking fees and education — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Boston Scientific at 46.3% of the total. Reporting peaked in 2019 at $167,190 and has fallen 78.4% since, to $36,147 in 2025. Among urology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$424,449in general payments, 2019–2025

Across 200 payments — averaging $2122.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$197K
Johnson & Johnson$108K
Calyxo, Inc.$36K
Olympus Corporation Of The Americas$35K
C. R. Bard, Inc. & Subsidiaries$31K
Auris Health, Inc.$6K
plus $12K from 10 others

$1,014,750in ownership & investment interests, 2019–2025

Across 6 payments — averaging $169,125 each. An ownership or investment interest held by the physician or an immediate family member.

Calyxo, Inc.$1M

What the payments were for

Consulting fees$198,80647%
Speaking & faculty fees$172,30741%
Travel & lodging$16,5864%
Food & beverage$3,3311%
Education$33,3308%
Gifts$890%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	77	$196,723
Johnson & Johnson	13	$107,882
Calyxo, Inc.	31	$36,355
Olympus Corporation Of The Americas	44	$34,650
C. R. Bard, Inc. & Subsidiaries	16	$30,821
Auris Health, Inc.	4	$6,343
Alnylam Pharmaceuticals Inc.	1	$3,780
Ambu A/s	2	$2,375
KARL Storz Endoscopy-america	2	$1,725
Olympus America Inc.	3	$1,620
Olympus Winter & Ibe GmbH	1	$1,080
Ambu Inc.	1	$950
Cook Medical LLC	1	$52
BD	2	$41
Coloplast	1	$33
Stryker	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

GENERAL KIDNEY STONE DISEASE$115,255
LithoVue$32,550
CVAC Aspiration System$29,836
Olympus Cystoscopes$19,091
ShockPulse - SE$19,091
VISERA ELITE$19,091
GENERAL - THERAPIES$18,230
Gyrus ACMI$9,125
UroPass$9,125
URETERO-RENO FIBERSCOPE$9,125
Olympus Stone Baskets and Retrievers$8,910
MONARCH$6,576
CVAC$6,000
OXLUMO$3,780
Moses 550 D\F\L$3,150
Flex-X$1,725
Soltive$1,620
Single Use Repositionable Clip$1,080
Bard Urinary Drainage Bag$152

How this compares

$424,449 in reported general payments places this provider in the 95th percentile of 327 urology providers in Massachusetts.

See all urology providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$369,784

Medicare patients

597

Services billed

2,290

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Potassium Citrate ErPotassium Citrate	31	$3,642
Silodosin	56	$3,534
Solifenacin Succinate	27	$1,748
Cefpodoxime Proxetil	32	$1,530
Trimethoprim	46	$559
Alfuzosin Hcl ErAlfuzosin Hcl	33	$549
Diclofenac Sodium ErDiclofenac Sodium	25	$345
Tamsulosin Hcl	34	$273
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst	29	$226
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	33	$158
Doxycycline Monohydrate	11	$130
Fluconazole	14	$59
Ciprofloxacin Hcl	15	$58

Paid to pharmacies, not to this prescriber.

Other urology in Boston

Christopher CutieBoston$3.5M
Stephen DretlerBoston$298K
Tony LuongoBoston$265K
Ricardo MunarrizBoston$118K
Mehrdad AlemozaffarBoston$95K
Adam KibelBoston$92K
Ruslan KoretsBoston$86K
Adam FeldmanBoston$74K
William BoysenBoston$56K
Shahin TabatabaeiBoston$55K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →